We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App





Breaking Research Throws Light on COVID, Flu, and RSV Co-Infections

By LabMedica International staff writers
Posted on 27 Jul 2023

At the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, researchers presented new data on co-infection rates of SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) in the United States. More...

This study provides one of the earliest insights into the interrelationship between these prevalent yet potentially lethal viruses and could contribute to enhanced diagnosis and patient management for these illnesses. After analyzing over 26,000 respiratory tests from US adults and children in late 2022, the researchers found co-infections in over 1% of positive cases, with the rate being particularly high in individuals below 21 years. These findings could impact how clinicians approach testing for respiratory diseases during future epidemics and seasonal outbreaks.

Respiratory viruses like RSV place substantial strain on public health systems. The likelihood of co-infections increases during multiple outbreaks of respiratory diseases, such as in the winter flu season. Patients with co-infections run a higher risk of developing severe disease and experiencing treatment complications, underlining the importance of understanding the prevalence of co-infections within the general population. Co-infections can be especially challenging during an epidemic. For instance, a surge in RSV cases in the US towards the end of 2022 coincided with the continuous spread of COVID-19 and the onset of the seasonal flu. However, there has been very less data defining co-infection rates during this RSV outbreak, which until recently lacked a vaccine.

Now, scientists at Quest Diagnostics (Marlborough, MA, USA) have presented one of the first comprehensive studies on co-infection rates in the US amidst the COVID-19 pandemic. In a retrospective study, they examined 26,657 respiratory tests collected from a clinical laboratory over a 107-day period in the fall of 2022, which included 9,800 samples from patients below 21 years. Using the Roche cobas and Cepheid Xpert platforms, they tested these samples for RSV, SARS-CoV-2, and influenza A/B.

The tests demonstrated that co-infections with two or more of these viruses occurred in 1.33% of positive cases and in .55% of all samples studied. The positivity rates varied depending on the viruses involved, ranging from .38% in adults for both SARS-CoV-2 and RSV to 2.28% in adults for both influenza A and SARS-CoV-2. However, co-infection rates in the pediatric group surpassed those in the adult population for all three viruses. A striking 6% co-infection rate of SARS-CoV-2 and influenza A in those under 21 was observed, which echoed previous findings by the Centers for Disease Control and Prevention in hospitalized pediatric patients.

“As we experience more flu-seasons and future epidemics of respiratory viruses, we’ll be able to acquire more co-infection rate data,” said lead scientist George Pratt, Ph.D., at Quest Diagnostics. “Our current work would make a useful data point to help evaluate whether future co-infection rates are shrinking or growing.”

Related Links:
Quest Diagnostics 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Giardia Assay
AccuDiag Giardia
New
Varicella Zoster Test
ZEUS ELISA Varicella Zoster IgG Test System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.